426 related articles for article (PubMed ID: 22955350)
1. The gut barrier: new acquisitions and therapeutic approaches.
Scaldaferri F; Pizzoferrato M; Gerardi V; Lopetuso L; Gasbarrini A
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S12-7. PubMed ID: 22955350
[TBL] [Abstract][Full Text] [Related]
2. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
3. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
Araújo F; Sarmento B
Int J Pharm; 2013 Dec; 458(1):128-34. PubMed ID: 24120728
[TBL] [Abstract][Full Text] [Related]
4. Intestinal barrier function in health and gastrointestinal disease.
Camilleri M; Madsen K; Spiller R; Greenwood-Van Meerveld B; Verne GN
Neurogastroenterol Motil; 2012 Jun; 24(6):503-12. PubMed ID: 22583600
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and probiotics in chronic liver diseases.
Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
[TBL] [Abstract][Full Text] [Related]
6. Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies.
Pereira C; Araújo F; Barrias CC; Granja PL; Sarmento B
Biomaterials; 2015 Jul; 56():36-45. PubMed ID: 25934277
[TBL] [Abstract][Full Text] [Related]
7. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability.
Dokladny K; Moseley PL; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G204-12. PubMed ID: 16407590
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
[TBL] [Abstract][Full Text] [Related]
9. H2 blockers decrease gut mucus production and lead to barrier dysfunction in vitro.
Diebel LN; Liberati DM; Hall-Zimmerman L
Surgery; 2011 Oct; 150(4):736-43. PubMed ID: 22000186
[TBL] [Abstract][Full Text] [Related]
10. Estrogen modulates intestinal mucus physiochemical properties and protects against oxidant injury.
Diebel ME; Diebel LN; Manke CW; Liberati DM
J Trauma Acute Care Surg; 2015 Jan; 78(1):94-9. PubMed ID: 25539208
[TBL] [Abstract][Full Text] [Related]
11. Role of intestinal permeability in monitoring mucosal barrier function. History, methodology, and significance of pathophysiology.
Sun Z; Wang X; Andersson R
Dig Surg; 1998; 15(5):386-97. PubMed ID: 9845620
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobicity of mucosal surface and its relationship to gut barrier function.
Qin X; Caputo FJ; Xu DZ; Deitch EA
Shock; 2008 Mar; 29(3):372-6. PubMed ID: 17693944
[TBL] [Abstract][Full Text] [Related]
13. Epithelial barrier: an interface for the cross-communication between gut flora and immune system.
Goto Y; Kiyono H
Immunol Rev; 2012 Jan; 245(1):147-63. PubMed ID: 22168418
[TBL] [Abstract][Full Text] [Related]
14. The role of mucoprotectants in the management of gastrointestinal disorders.
Eutamene H; Beaufrand C; Harkat C; Theodorou V
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):83-90. PubMed ID: 28946778
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model.
Generoso SV; Viana M; Santos R; Martins FS; Machado JA; Arantes RM; Nicoli JR; Correia MI; Cardoso VN
Arch Microbiol; 2010 Jun; 192(6):477-84. PubMed ID: 20437166
[TBL] [Abstract][Full Text] [Related]
16. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
17. Keeping bugs in check: The mucus layer as a critical component in maintaining intestinal homeostasis.
Faderl M; Noti M; Corazza N; Mueller C
IUBMB Life; 2015 Apr; 67(4):275-85. PubMed ID: 25914114
[TBL] [Abstract][Full Text] [Related]
18. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
19. Gut barrier in health and disease: focus on childhood.
Viggiano D; Ianiro G; Vanella G; Bibbò S; Bruno G; Simeone G; Mele G
Eur Rev Med Pharmacol Sci; 2015; 19(6):1077-85. PubMed ID: 25855935
[TBL] [Abstract][Full Text] [Related]
20. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways.
Neunlist M; Toumi F; Oreschkova T; Denis M; Leborgne J; Laboisse CL; Galmiche JP; Jarry A
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1028-36. PubMed ID: 12881224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
